Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023

Loading...
Loading...

Upgrades

TD Securities upgraded the previous rating for BlackBerry Ltd BB from Reduce to Hold. BlackBerry earned $0.02 in the fourth quarter, compared to $0.01 in the year-ago quarter. The stock has a 52-week-high of $7.82 and a 52-week-low of $3.17. At the end of the last trading period, BlackBerry closed at $4.00.

According to Benchmark, the prior rating for Howmet Aerospace Inc HWM was changed from Neutral to Buy. For the fourth quarter, Howmet Aerospace had an EPS of $0.38, compared to year-ago quarter EPS of $0.30. The current stock performance of Howmet Aerospace shows a 52-week-high of $44.37 and a 52-week-low of $29.85. Moreover, at the end of the last trading period, the closing price was at $41.94.

According to Barclays, the prior rating for Advance Auto Parts Inc AAP was changed from Underweight to Equal-Weight. Advance Auto Parts earned $2.88 in the fourth quarter, compared to $2.07 in the year-ago quarter. At the moment, the stock has a 52-week-high of $231.06 and a 52-week-low of $109.05. Advance Auto Parts closed at $118.61 at the end of the last trading period.

Jefferies upgraded the previous rating for Zimmer Biomet Holdings Inc ZBH from Underperform to Hold. Zimmer Biomet Holdings earned $1.88 in the fourth quarter, compared to $1.95 in the year-ago quarter. At the moment, the stock has a 52-week-high of $135.00 and a 52-week-low of $100.41. Zimmer Biomet Holdings closed at $126.76 at the end of the last trading period.

According to TD Cowen, the prior rating for Pacific Biosciences of California Inc PACB was changed from Market Perform to Outperform. For the fourth quarter, Pacific Biosciences had an EPS of $0.35, compared to year-ago quarter EPS of $0.30. The current stock performance of Pacific Biosciences shows a 52-week-high of $14.14 and a 52-week-low of $3.85. Moreover, at the end of the last trading period, the closing price was at $9.76.

For Restaurant Brands International Inc QSR, TD Cowen upgraded the previous rating of Market Perform to Outperform. Restaurant Brands Intl earned $0.72 in the fourth quarter, compared to $0.74 in the year-ago quarter. The stock has a 52-week-high of $68.89 and a 52-week-low of $46.69. At the end of the last trading period, Restaurant Brands Intl closed at $65.22.

See all analyst ratings upgrades.

Downgrades

For Healthpeak Properties Inc PEAK, Scotiabank downgraded the previous rating of Sector Outperform to Sector Perform. In the fourth quarter, Healthpeak Properties showed an EPS of $0.44, compared to $0.41 from the year-ago quarter. At the moment, the stock has a 52-week-high of $35.71 and a 52-week-low of $20.21. Healthpeak Properties closed at $21.69 at the end of the last trading period.

B of A Securities downgraded the previous rating for Generac Holdings Inc GNRC from Neutral to Underperform. For the fourth quarter, Generac Hldgs had an EPS of $1.78, compared to year-ago quarter EPS of $2.51. The current stock performance of Generac Hldgs shows a 52-week-high of $329.94 and a 52-week-low of $86.29. Moreover, at the end of the last trading period, the closing price was at $111.97.

For Avidity Biosciences Inc RNA, Evercore ISI Group downgraded the previous rating of Outperform to In-Line. For the fourth quarter, Avidity Biosciences had an EPS of $0.88, compared to year-ago quarter EPS of $0.82. The current stock performance of Avidity Biosciences shows a 52-week-high of $25.74 and a 52-week-low of $9.88. Moreover, at the end of the last trading period, the closing price was at $16.80.

For Cintas Corp CTAS, Jefferies downgraded the previous rating of Buy to Hold. Cintas earned $3.14 in the third quarter, compared to $2.69 in the year-ago quarter. At the moment, the stock has a 52-week-high of $470.05 and a 52-week-low of $344.16. Cintas closed at $467.64 at the end of the last trading period.

Loop Capital downgraded the previous rating for JD.com Inc JD from Buy to Hold. In the fourth quarter, JD.com showed an EPS of $0.70, compared to $0.35 from the year-ago quarter. The stock has a 52-week-high of $68.29 and a 52-week-low of $33.17. At the end of the last trading period, JD.com closed at $44.40.

See all analyst ratings downgrades.

Initiations

CJS Securities initiated coverage on RadNet Inc RDNT with an Outperform rating. The price target for RadNet is set to $30.00. In the fourth quarter, RadNet showed an EPS of $0.11, compared to $0.13 from the year-ago quarter. The current stock performance of RadNet shows a 52-week-high of $25.78 and a 52-week-low of $12.14. Moreover, at the end of the last trading period, the closing price was at $24.48.

With a Buy rating, Craig-Hallum initiated coverage on Integral Ad Science Holding Corp IAS. The price target seems to have been set at $18.00 for Integral Ad Science. Integral Ad Science earned $0.07 in the fourth quarter, compared to $0.03 in the year-ago quarter. The current stock performance of Integral Ad Science shows a 52-week-high of $15.20 and a 52-week-low of $6.64. Moreover, at the end of the last trading period, the closing price was at $13.79.

With an Outperform rating, CJS Securities initiated coverage on Helios Technologies Inc HLIO. The price target seems to have been set at $78.00 for Helios Technologies. For the fourth quarter, Helios Technologies had an EPS of $0.78, compared to year-ago quarter EPS of $1.01. At the moment, the stock has a 52-week-high of $80.92 and a 52-week-low of $48.41. Helios Technologies closed at $64.65 at the end of the last trading period.

B. Riley Securities initiated coverage on Silk Road Medical Inc SILK with a Buy rating. The price target for Silk Road Medical is set to $58.00. In the fourth quarter, Silk Road Medical showed an EPS of $0.34, compared to $0.42 from the year-ago quarter. The current stock performance of Silk Road Medical shows a 52-week-high of $58.04 and a 52-week-low of $27.32. Moreover, at the end of the last trading period, the closing price was at $38.93.

With a Neutral rating, Citigroup initiated coverage on Cardinal Health Inc CAH. The price target seems to have been set at $77.00 for Cardinal Health. Cardinal Health earned $1.32 in the second quarter, compared to $1.27 in the year-ago quarter. The stock has a 52-week-high of $81.57 and a 52-week-low of $49.71. At the end of the last trading period, Cardinal Health closed at $75.35.

With a Buy rating, Citigroup initiated coverage on AmerisourceBergen Corp ABC. The price target seems to have been set at $185.00 for AmerisourceBergen. AmerisourceBergen earned $2.71 in the first quarter, compared to $2.58 in the year-ago quarter. The stock has a 52-week-high of $174.63 and a 52-week-low of $135.16. At the end of the last trading period, AmerisourceBergen closed at $159.34.

With a Buy rating, Citigroup initiated coverage on McKesson Corp MCK. The price target seems to have been set at $420.00 for McKesson. For the third quarter, McKesson had an EPS of $6.90, compared to year-ago quarter EPS of $6.15. At the moment, the stock has a 52-week-high of $401.54 and a 52-week-low of $298.89. McKesson closed at $357.78 at the end of the last trading period.

With an Overweight rating, Piper Sandler initiated coverage on Immunovant Inc IMVT. The price target seems to have been set at $28.00 for Immunovant. Immunovant earned $0.49 in the third quarter, compared to $0.36 in the year-ago quarter. The current stock performance of Immunovant shows a 52-week-high of $20.24 and a 52-week-low of $3.15. Moreover, at the end of the last trading period, the closing price was at $15.47.

Stephens & Co. initiated coverage on 10x Genomics Inc TXG with an Overweight rating. The price target for 10x Genomics is set to $65.00. 10x Genomics earned $0.15 in the fourth quarter, compared to $0.16 in the year-ago quarter. The stock has a 52-week-high of $83.28 and a 52-week-low of $23.85. At the end of the last trading period, 10x Genomics closed at $52.05.

Loop Capital initiated coverage on Jack In The Box Inc JACK with a Buy rating. The price target for Jack In The Box is set to $114.00. Jack In The Box earned $2.01 in the first quarter, compared to $1.97 in the year-ago quarter. The current stock performance of Jack In The Box shows a 52-week-high of $94.62 and a 52-week-low of $54.86. Moreover, at the end of the last trading period, the closing price was at $84.76.

Mizuho initiated coverage on Immunocore Holdings PLC IMCR with a Buy rating. The price target for Immunocore Hldgs is set to $70.00. In the fourth quarter, Immunocore Hldgs showed an EPS of $0.63, compared to $1.21 from the year-ago quarter. At the moment, the stock has a 52-week-high of $69.01 and a 52-week-low of $25.04. Immunocore Hldgs closed at $47.52 at the end of the last trading period.

With a Buy rating, Mizuho initiated coverage on Immatics NV IMTX. The price target seems to have been set at $12.00 for Immatics. For the fourth quarter, Immatics had an EPS of $0.23, compared to year-ago quarter EPS of $0.30. The stock has a 52-week-high of $13.60 and a 52-week-low of $5.75. At the end of the last trading period, Immatics closed at $7.18.

With a Buy rating, Mizuho initiated coverage on Vigil Neuroscience Inc VIGL. The price target seems to have been set at $15.00 for Vigil Neuroscience. For the fourth quarter, Vigil Neuroscience had an EPS of $0.48, compared to year-ago quarter EPS of $8.28. The current stock performance of Vigil Neuroscience shows a 52-week-high of $16.50 and a 52-week-low of $2.18. Moreover, at the end of the last trading period, the closing price was at $9.99.

With a Buy rating, Mizuho initiated coverage on Amylyx Pharmaceuticals Inc AMLX. The price target seems to have been set at $52.00 for Amylyx Pharma. Amylyx Pharma earned $0.65 in the fourth quarter, compared to $4.10 in the year-ago quarter. The stock has a 52-week-high of $41.93 and a 52-week-low of $6.51. At the end of the last trading period, Amylyx Pharma closed at $27.71.

See all analyst ratings initiations.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...